A new initiative at the University of Washington’s Institute for Protein Design (IPD) aims to advance the development of designer proteins and enzymes, backed by a substantial grant of $7 million. This program, led by Nobel Laureate David Baker, is focused on addressing challenges in medicine, technology, and sustainability.
The funding from the Washington Research Foundation (WRF) will support the IPD's goal over the next four years, including the education of new scientists and the creation of commercially viable tools as well as startup ventures. Baker, who recently received the 2024 Nobel Prize in Chemistry, emphasizes the potential of artificial intelligence in designing proteins tailored for specific tasks.
IPD has successfully launched over 10 startups, including notable acquisitions by major companies like Takeda and AstraZeneca. The initiative will receive its first funding installment in June, with additional support from prominent philanthropists and organizations. Furthermore, the University of Washington is enhancing IPD's facilities in Seattle's South Lake Union to facilitate this ambitious project.